Andorra vs Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand): Proportion of the target population who received the final dose of
Andorra
82.0%
in 2024
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
44.0%
in 2024
Andorra rank
20th
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) rank
17th
Proportion of the target population who received the final dose of over time
- Andorra
- Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
How they compare
Andorra currently reports 82.0% against 44.0% in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand), a difference of 38.0%.
That makes Andorra's figure about 1.9 times Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)'s.
Across all 7 years both countries report, Andorra has been ahead every year.
Andorra ranks 20th and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 17th of 107 countries.
Andorra has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Andorra | Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.5% | 37.5% | 19.0% | Andorra |
| 2020s | 82.0% | 41.4% | 40.6% | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Andorra or Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- Andorra, at 82.0% against 44.0% in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Andorra and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- 38.0%, with Andorra ahead.
- How many years of comparable data are there for Andorra and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- 7 years are reported by both, from 2018 to 2024.
- How do Andorra and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) rank globally for proportion of the target population who received the final dose of?
- Andorra ranks 20th and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 17th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.